Angiotensin AT2 receptor-mediated neuroprotection and nitric oxide-bioavailability in stroke.
Tsuda
Kazushi
K
D057912:Angiotensin II Type 2 Receptor Blockers; D000818:Animals; D001682:Biological Availability; D004195:Disease Models, Animal; D007093:Imidazoles / Q000494:pharmacology; D008560:Membrane Fluidity / Q000187:drug effects; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D011918:Rats, Inbred SHR; D044139:Receptor, Angiotensin, Type 2 / Q000819:agonists / Q000378:metabolism*; D020521:Stroke / Q000378:metabolism* / Q000517:prevention & control*
D057912:Angiotensin II Type 2 Receptor Blockers; D007093:Imidazoles; D009842:Oligopeptides; D011725:Pyridines; D044139:Receptor, Angiotensin, Type 2; C060894:CGP 42112A; C073402:PD 123319; D009569:Nitric Oxide; D052250:Nitric Oxide Synthase Type III